Background: Inflammation plays a pivotal role in blood pressure regulation. Current data reflect the important role of T cells in primary hypertension. The role of dendritic cells (DC) in secondary hypertension- primary aldosteronism (PA) remains unknown. The aim of this study was to quantify peripheral blood T lymphocytes, plasmacytoid dendritic cells (pDCs) and inflammatory markers in individuals with PA comparing to essential hypertension (HTN).
Methods: 39 patients with PA and 15 patients with HTN were enrolled. Clinical data, serum aldosterone concentration, ambulatory blood pressure monitoring (ABPM), echocardiography, and phenotype of peripheral blood cells with the usage of flow cytometry were assessed.
Results: No differences were found in terms of age, sex and BMI between the groups. In both groups, similar levels of systolic and diastolic blood pressure on ABPM were noted. Both PA and HTN were associated with cardiac hypertrophy (LVMI). In comparison with HTN, PA patients had a notably higher percentage of pDC characterized by co-expression of CD123 and CD303. A positive correlation between aldosterone concentration and the percentage of CD123+CD303+ pDC in the PA was observed. The PA group exhibited lower concentrations of RANTES, TNF-α, CD40L, and VEGF compared to the HTN group.
Conclusions: Higher aldosterone concentration was connected with the increased numbers of plasmacytoid pDC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ajh/hpaf019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the high prevalence, comorbidities, and indicators of mild autonomous cortisol secretion in primary aldosteronism: a cohort study and systematic review.
Hypertens Res
March 2025
Renal Division, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Emerging evidence has suggested a significant prevalence of mild autonomous cortisol secretion (MACS) among patients diagnosed with primary aldosteronism (PA). However, MACS's clinical characteristics and implications in PA patients remain largely unexplored. To investigate the prevalence, comorbidities, and indicators of MACS in PA patients, we conducted a retrospective cohort study including 874 PA patients with dexamethasone suppression test results in the Taiwan Primary Aldosteronism Investigators (TAIPAI) cohort between February 2011 and February 2024.
View Article and Find Full Text PDFEffect of Age on Aldosterone-Renin Ratio in Screening Primary Aldosteronism.
J Clin Hypertens (Greenwich)
March 2025
The Department of Endocrinology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Primary aldosteronism (PA) is the most common endocrine cause of hypertension. The plasma aldosterone-to-renin ratio (ARR) is the most recommended screening tool for PA, but previous studies showed controversy regarding the influence of age on ARR. The aim of the study was to evaluate the impact of age on ARR measured using direct renin concentration (DRC) and its diagnostic value in patients with PA.
View Article and Find Full Text PDFHormonal and metabolic responses across phases of combined oral contraceptive use and menstrual cycle in young elite female athletes.
Eur J Appl Physiol
March 2025
CIAMS, Université d'Orléans, Pôle STAPS, Orléans, France.
Purpose: Despite the significant number of female athletes using combined oral contraceptives (COCs), there is scant literature on their hormonal and metabolic effects across different phases.
Methods: In order to contribute to a wider knowledge of COC-action mechanisms involved in athletes' performance and health, we therefore examined the effects of low-dose monophasic COC (ethinylestradiol/levonorgestrel) intake on sex hormones (estradiol, progesterone, sex hormone binding protein (SHBG)) as well as on a large number of pituitary (LH, TSH, prolactin) and peripheral (triiodothyronine, cortisol, DHEA, DHEA-S, aldosterone, osteocalcin, 25(OH)D) basal hormone levels in nine young elite female athletes, across COC administration (first and second half of active hormone intake, washout phases), compared to eleven female athletes without hormonal contraception across their normal menstrual cycle (NMC, i.e.
Plasmacytoid dendritic cell content is associated with plasma aldosterone concentration in patients with primary aldosteronism.
Am J Hypertens
March 2025
Department of Hypertension, National Institute of Cardiology, Warsaw, Poland.
Background: Inflammation plays a pivotal role in blood pressure regulation. Current data reflect the important role of T cells in primary hypertension. The role of dendritic cells (DC) in secondary hypertension- primary aldosteronism (PA) remains unknown.
View Article and Find Full Text PDFUnveiling the benefits of Vitamin D3 with SGLT-2 inhibitors for hypertensive obese obstructive sleep apnea patients.
J Transl Med
March 2025
Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, 56000, Kuala Lumpur, Malaysia.
Background: Obstructive sleep apnea (OSA) is associated with poorer quality of life (QoL) and increased cardiovascular risks, which may be exacerbated by hypovitaminosis D. Sodium glucose transporter-2 inhibitor (SGLT2i) provides cardiovascular benefits beyond glycemic control. As vitamin D3 and SGLT2i act through different pathways with similar mechanisms in improving cardio-metabolic health, this study aimed to investigate the synergistic effects of this combination therapy in improving these parameters and QoL in hypertensive obese OSA patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!